Navigators are an increasingly essential component of a comprehensive, patient-centered cancer program. However, given their expansive—and often poorly defined—role, it can be difficult to track their direct impact on quality and financial outcomes. But that's exactly what Cone Health Cancer Center-Alamance Regional in North Carolina has done since using Oncology Roundtable resources to help them add a second lung cancer navigator. Keep reading to see how Cone Health made the case and tracked the downstream impact—to the tune of an estimated $750,000 in additional revenue per year.